2740 results
NOAC / DOAC Pharmacology and Prescribing Cheat Sheet
Novel (or Direct) Oral Anti-Coagulants
 • Rivaroxaban
 • Apixaban
NOAC / DOAC Pharmacology ... #NOAC #DOAC #Pharmacology ... Prescribing #hematology #management
Best practice recommendations for the diagnosis and treatment of adult patients experiencing traumatic brain injury during
Brain #Injury #NOAC ... #DOAC #Management
Restarting Anticoagulation after TIA or Acute Ischemic Stroke

 • TIA → Consider (re-) starting a NOAC
re-) starting a NOAC ... re-) starting a NOAC ... re-)starting a NOAC ... re-) starting a NOAC ... CVA #neurology #management
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
heparin #LMWH #NOAC ... dabigatran #Pradaxa #management
DOAC Reversal
Emergency surgery or urgent procedure
Stop anticoagulant treatment; volume resuscitation and transfusion as needed
Antidotes:
 • Apixaban,
DOAC Reversal Emergency ... not available #DOAC ... #Reversal #NOAC ... anticoagulant #hematology #management
ED Opioid Stewardship Algorithm

Opioid Naive vs Opioid Tolerant

1. Patient Specific, Pain Syndrome-Targeted Approach
2. Combinations of Non-Pharmacologic
Non-Opioid Analgesia (NOA ... Stewardship #Algorithm #Management
Warfarin and DOAC Pharmacology
Warfarin - Dabigatran - Rivaroxaban - Apixaban - Edoxaban
Target - Prodrug - Bioavailability
Warfarin and DOAC ... h) #Warfarin #DOAC ... #Pharmacology #NOAC
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
anticoagulation #doac ... #noac #pharmacology
Pharmacokinetic Characteristics and Primary Routes of Clearance of Oral Anticoagulant Agents

Warfarin - 100% Hepatic, 0% Renal
Apixaban
Hepatic, 35% Renal #DOAC ... #NOAC #Metabolism
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Noah Rosenberg @ ... APML #diagnosis #management